Abstract
Our better understanding of the PCNSV spectrum and its subsets will facilitate early recognition. This may facilitate earlier treatment and may prevent irreversible or even lethal outcomes.
Original language | English (US) |
---|---|
Pages (from-to) | 46-52 |
Number of pages | 7 |
Journal | Current opinion in rheumatology |
Volume | 24 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2012 |
Keywords
- Amyloid angiopathy
- Clinical subsets
- Diagnostic criteria
- Immunosuppressive therapy
- Primary central nervous system vasculitis
ASJC Scopus subject areas
- Rheumatology